Evaluation of Immunostaining for MIB1 and nm23 Products in Uterine Cervical Adenocarcinoma

Tohoku Journal of Experimental Medicine

Volumn 185, Issue 3, 1998, Pages 185-197

  Morimura, Yutaka ^a   Yanagida, Kaoru ^a   Hashimoto, Toshihiro ^a   Takano, Yoshimasa ^a   Watanabe, Fuminori ^a   Yamada, Hidekazu ^a   Sato, Akira ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cervical adenocarcinoma; Immunohistochemistry; MIB1; nm23; Prognosis

Indexed keywords

CELL NUCLEUS ANTIGEN; MONOCLONAL ANTIBODY; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; NUCLEAR PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE A; TRANSCRIPTION FACTOR;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; STAINING; SURVIVAL; TUMOR RECURRENCE; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, NUCLEAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; PROPORTIONAL HAZARDS MODELS; STAINING AND LABELING; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0032106606     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.185.185     Document Type: Article

References (36)

1. Angel, C., DuBeshter, B. & Lin, J.Y. (1992) Clinical presentation and management of stage I cervical adenocarcinoma: A 25 years experience. Gynecol. Oncol., 44, 71-78.
2. Barnes, R., Masood, S., Barker, E., Rosengard, A.M., Coggin, D.L., Crowell, T., King, C.R., Porter-Jordan, K., Wargotz, E.S., Liotta, L.A. & Steeg, P.S. (1991) Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am. J. Pathol., 139, 245-250.
3. Berek, J.S., Hacker, N.F., Fu, Y., Sokale, J.R., Leuchter, R.C. & Lagasse, L.D. (1985) Adenocarcinoma of the utrine cervix: Histologic variables associated with lymph node metastasis and survival. Obstet. Gynecol., 65, 46-52.
4. Cattoretti, G., Becker, H.G., Key, G., Duchrow, M., Schlüter, C., Galle, J. & Gerdes, J. (1992) Monoclonal antibodies against recombinant parts of Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol., 168, 358-363.
5. Devesa, S., Young, J., Brinton, L. & Fraumein, J. (1989) Recent trends in cervix uteri cancer. Cancer, 64, 2184-2190.
6. Eifel, P.J., Morris, M., Oswald, M.J., Wharton, J.T. & Delclos, L. (1990) Adenocarcinoma of the uterine cervix. Cancer, 65, 71-78.
7. Engel, M., Theisinger, B., Seib, T., Seitz, G., Huwer, H., Zang, K.D., Welter, C. & Dooley, S. (1993) High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages. Int. J. Cancer, 55, 375-379.
8. Florens, V.A, Aamdal, S., Myklebost, O., Maelandsmo, G.M., Bruland, O. & Fodstad, O. (1992) Levels of nm23 messenger RNA in metastatic malignant melanoma: Inverse correlation to disease progression. Cancer Res., 52, 6088-6091.
9. Geiser J.P., Wiemann, M.C., Zhou, Z., Miller, G.A. & Geisler, H.E. (1996) Proliferation index determination by MIB1 and recurrence in endometrial cancer. Gynecol. Oncol., 61, 373-377.
10. Gerdes, J., Lemke, H., Baisch, H. & Stein, H. (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol., 133, 1710-1715.
11. Greer, B.E., Figge, D.C., Tamimi, H.K. & Cain, J.M. (1989) Stage Ib adenocarcinoma of the cervix treated by radical hysterectomy and pelvic lymph node dissection. Am. J. Obstet. Gynecol., 160, 1509-1514.
12. Hailat, N., Keim, D.R., Melhem, R.F., Zhu, X.X., Eckerskorn, C., Brodeur, G.M., Reynolds, C.P., Seeger, R.C., Lottspeich, F., Strahler, J.R. & Hanash, S.M. (1991) High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J. Clin. Invest., 88, 341-345.
13. Hirayama, R., Sawai, S., Takagi, Y., Mishima, Y., Kimura, N., Shimada, N., Esaki, Y., Kurashima, C., Utsuyama, M. & Hirokawa, K. (1991) Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate-kinase) and good prognosis in human breast cancer. J. Natl. Cancer Inst., 83, 1249-1250.
14. Hopkins, M.P., Schmidt, R.W., Roberts, J.A. & Morley, G.W. (1988) The prognosis and treatment of stage I adenocarcinoma of the cervix. Obstet. Gynecol., 72, 915-921.
15. Igawa, M., Rukstalis, D.B., Tanabe, T. & Chodak, G.W. (1994) High leves of nm23 expression are related to cell proliferation in human prostate cancer. Cancer Res., 54, 1313-1318.
16. Kerns, B.M., Jordan, P.A., Faerman, L.L., Berchuck, A., Bast, R.C. & Layfield, L.J. (1994) Determination of proliferation index with MIB1 in advanced ovarian cancer using quantitative image analysis. Am. J. Clin. Pathol., 101, 192-197.
17. Korhonen, M.O. (1984) Adenocarcinoma of the uterine cervix: Prognosis and prognotic significance of histology. Cancer, 53, 1760-1763.
18. Kristensen, G.B., Holm, R., Abeler, V.M. & Trope, C.G. (1996) Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: An immunohistochemical study. Gynecol. Oncol., 61, 378-383.
19. Liotta, L.A. & Steeg, P.S. (1988) Clues to the function of nm23 and Awd proteins in development, signal transduction and tumor metastasis provided by studies of Dictyostelium discoideum. J. Natl. Cancer Inst., 151, 248-256.
20. Mandai, M., Konishi, I., Koshiyama, M., Komatsu, T., Yamamoto, S., Nanbu, K., Mori, T. & Fukumoto, M. (1995) Alternated expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix. Cancer, 75, 2523-2529.
21. Matthews, C.M., Burke, T.W., Tornos, C., Eifel, P.J., Atkinson, E.N., Stringer, C.A., Morris, M. & Silva, E. (1993) Stage I cervical adenocarcinoma: Prognostic evaluation of surgically treated patients. Gynecol. Oncol., 49, 19-23.
22. Miller, B.E., Flax, S.D., Arheart, K. & Photopulos, G. (1993) The presentation of adenocarcinoma of the utrine cervix. Cancer, 72, 1281-1285.
23. Milson, I. & Friberg, L.G. (1983) Primary adenocarcinoma of the uterine cervix. Cancer, 52, 942-947.
24. Morimura, Y., Hoshi, K., Hang, X.L., Takano, Y., Ohishi, M., Honda, T., Yamada, H. & Sato, A. (1996) Evaluation with MIB1 antibody of proliferative activity in ovarian clear cell adenocarcinoma. Int. J. Gynecol. Pathol., 15, 315-319.
25. Nakanishi, S., Ishikawa, O., Ohhigashi, H., Kameyama, M., Furukawa, H., Sasaki, Y., Inaji, H., Higashiyama, M., Imaoka, S., Iwanaga, T., Funai, H., Wada, A. & Kimura, N. (1993) Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: An association with lymph node metastasis and tumor invasion. Clin. Exp. Metastasis., 11, 151-158.
26. Peters, R.K., Chao, A., Mack, T.M., Thomas, D., Bernstein, L. & Henderson, B.E. (1986) Increased frequency of adenocarcinoma of uterine cervix in young women in Los Angeles Country. J. Natl. Cancer Inst., 76, 423-428.
27. Schwart, B.R., Geraldine, P., Bacus, S., Toder, M. & Weineberg, D.S. (1989) Cell proliferation in non-Hodgkin's lymphomas. Am. J. Pathol., 134, 327-335.
28. Schwartz, S.M. & Weiss, N.S. (1986) Increased incidence of adenocarcinoma of the cervix in young women in United States. Am. J. Epidemiol. 124, 1045-1047.
29. Shepherd, N.A., Richman, P.I. & England, J. (1988) Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations. J. Pathol., 155, 213-219.
30. Shi, S.R., Key, M.E. & Kalra, K.L. (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39, 741-748.
31. Soomro, I.N. & Whimster, W. (1990) Growth fraction in lung tumors determination by Ki-67 immunostaining and comparison with AgNOR scores. J. Pathol., 162, 217-222.
32. Srivatsa, P.J., Cliby, W.A., Keeney, G.L., Dodson, M.K., Suman, V.J., Roche, P.C. & Podratz, K.C. (1996) Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma. Gynecol. Oncol., 60, 363-372.
33. Steeg, P.S., Bevilacqua, G., Kopper, L., Thorgeirsson, U.P., Talmadge, J.E., Liotta, L.A. & Sobel, M.E. (1988) Evidence for a nevel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst., 80, 200-204.
34. Walker, R.A. & Camplejohn, R.S. (1988) Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas. Br. J. Cancer, 57, 281-283.
35. Yamaguchi, A., Urano, T., Goi, T., Takeuchi, K., Niimoto, S., Nakagawa, G., Furukawa, K. & Shiku, H. (1994) Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma. Cancer, 73, 2280-2284.
36. Zou, M., Shi, Y., Al Sedairy, S. & Farid, N.R. (1993) High levels of nm23 gene expression in advanced stage of thyroid carcinomas. Br. J. Cancer, 68, 385-388.